PMS41 - Cost-Effectiveness Of Denosumab In The Treatment Of Postmenopausal Osteoporosis (Pmo) Women In Mexico At High Risk Of Fractures And Intolerant To Oral Bisphosphonates

Autor: Arocho, R., Rivera Hurtado, R., Salinas Escudero, G.
Zdroj: In Value in Health May 2013 16(3):A225-A225
Databáze: ScienceDirect